Brain organoids: A revolutionary tool for modeling neurological disorders and development of therapeutics
- PMID: 38013504
- PMCID: PMC10842775
- DOI: 10.1002/bit.28606
Brain organoids: A revolutionary tool for modeling neurological disorders and development of therapeutics
Abstract
Brain organoids are self-organized, three-dimensional (3D) aggregates derived from pluripotent stem cells that have cell types and cellular architectures resembling those of the developing human brain. The current understanding of human brain developmental processes and neurological disorders has advanced significantly with the introduction of this in vitro model. Brain organoids serve as a translational link between two-dimensional (2D) cultures and in vivo models which imitate the neural tube formation at the early and late stages and the differentiation of neuroepithelium with whole-brain regionalization. In addition, the generation of region-specific brain organoids made it possible to investigate the pathogenic and etiological aspects of acquired and inherited brain disease along with drug discovery and drug toxicity testing. In this review article, we first summarize an overview of the existing methods and platforms used for generating brain organoids and their limitations and then discuss the recent advancement in brain organoid technology. In addition, we discuss how brain organoids have been used to model aspects of neurodevelopmental and neurodegenerative diseases, including autism spectrum disorder (ASD), Rett syndrome, Zika virus-related microcephaly, Alzheimer's disease (AD), Parkinson's disease (PD), and Huntington's disease (HD).
Keywords: embryoid bodies (EBs); human brain organoids (HBOs); human induced pluripotent stem cells (hiPSCs); neural progenitor cells (NPCs); neurological disorders.
© 2023 Wiley Periodicals LLC.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Al Mamun A, Sahab Uddin M, Fahim Bin Bashar M, Zaman S, Begum Y, Bulbul IJ, Siddiqul Islam M, Shahid Sarwar M, Mathew B, Shah Amran M, Md Ashraf G, Bin-Jumah MN, Mousa SA, & Abdel-Daim MM (2020). Molecular insight into the therapeutic promise of targeting ApoE4 for Alzheimer’s disease. Oxidative Medicine and Cellular Longevity, 2020. 10.1155/2020/5086250 - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
